South Asians With Type 2 Diabetes at Risk for Depression
Part of paid clinical trials in New York, New York.
- Sponsor
- NYU Langone Health
- Study ID
- NCT07219667
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- CHW-led T2D Intervention — BEHAVIORALCHW-led T2D intervention that includes mental health and digital health components.
Study Details
This study will adapt a community health worker (CHW)-led Type 2 diabetes (T2D) intervention to include mental health and digital components using a trauma informed care approach, and test the feasibility and acceptability of this intervention to support South Asians with T2D at risk for depression.
Key Dates
- Start date
- Aug 1, 2027
- Status verified
- May 2026
- Primary completion
- Jun 1, 2028
- Completion
- Jun 1, 2028
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Adult South Asian patients in the New York City (NYC) regionIn Aim 3, CHWs will provide culturally and linguistically tailored health education to South Asian participants on the management of T2D and depressive symptoms.
Primary Outcome Measure
Change in HbA1c Levels [ Time Frame: Baseline, Month 3 ]
Central Contacts
- Naheed Ahmed, PhD646-501-3751
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| NYU Langone Health | New York | New York | 10016 | - |
Find similar trials in New York, NY
By condition
By specialty
By research site
Related Studies
- Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes PatientsPHASE1/PHASE2 · Not Yet Recruiting · ARKAY Therapeutics · Albany, New York
- Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes MellitusNot Yet Recruiting · Bionime Corporation · Guntersville, Alabama
- Novel Digital Patient-Reported Outcomes Tool for Diabetes ManagementRecruiting · NYU Langone Health · New York, New York
- Implementing an Effective Diabetes Intervention Among Low-Income ImmigrantsRecruiting · NYU Langone Health · New York, New York